Stock Events

Stock Events

C4 Therapeutics (CCCC) Q4 2024 Earnings

31OctConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.69

-0.54

-0.4

-0.26

Details

Expected EPS

-0.378971

Actual EPS

-0.35

Surprise EPS

0.03

Surprise Percent

+7.64%

Description

C4 Therapeutics (CCCC) has reported earnings of -0.35 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.